fendiline has been researched along with Chronic Disease in 4 studies
Fendiline: Coronary vasodilator; inhibits calcium function in muscle cells in excitation-contraction coupling; proposed as antiarrhythmic and antianginal agents.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Candau, LA | 1 |
| Pereira, LS | 1 |
| Lavall, MA | 1 |
| Carvalho, CR | 1 |
| Vichi, FL | 1 |
| Armaganijan, D | 1 |
| Batlouni, M | 1 |
| de Araújo, JR | 1 |
| Kuz'ko, NV | 1 |
3 trials available for fendiline and Chronic Disease
| Article | Year |
|---|---|
[Comparative study of verapamil and fendiline in the treatment of chronic coronary insufficiency. Clinical and ergometric evaluation].
Topics: Chronic Disease; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Electrocardiograph | 1982 |
[Fendiline hydrochloride as a therapeutic agent in chronic coronary insufficiency].
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Coronary Disease; Electrocardiography; Exerc | 1980 |
[Cycloergometric evaluation of fendiline in chronic coronary insufficiency].
Topics: Chronic Disease; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Electrocardiograph | 1979 |
1 other study available for fendiline and Chronic Disease
| Article | Year |
|---|---|
[Calcium antagonists and adenosine derivatives in the treatment of patients with chronic ischemic heart disease].
Topics: Adenosine; Aged; Calcium Channel Blockers; Chronic Disease; Coronary Disease; Drug Evaluation; Drug | 1988 |